Cite

HARVARD Citation

    Oshima, M. et al. (2019). Tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: A case report. IJU case reports. 2 (4), pp. 179-182. [Online]. 
  
Back to record